Emrah Aras, M.D.

Associate Director, Global Medical Affairs Digital Health Lead at Alexion AstraZeneca Rare Disease

Emrah Aras, M.D. is a healthcare professional with extensive experience in the pharmaceutical industry, currently serving as the Associate Director, Digital Health Program Lead at Alexion Pharmaceuticals, Inc.1 Here's a detailed overview of his background and career:

Education

Emrah Aras holds an M.D. from Gazi Üniversitesi and an MHA (Master of Health Administration) from Long Island University.1 He also completed his high school education at TED Ankara Koleji, specializing in Mathematics.1

Professional Experience

Current Role:

Associate Director, Digital Health Program Lead at Alexion Pharmaceuticals, Inc. (May 2022 - Present)1

Previous Positions at Alexion Pharmaceuticals:

Associate Director, Data Generation & Insights Strategy (February 2021 - May 2022)
Project Manager, Medical Affairs Excellence (April 2020 - February 2021)1

Other Notable Roles:

Project Management Consultant for a biotech company specializing in rare diseases
Project Manager for Health Economics and Value Assessment at Sanofi Genzyme
Global Market Access Director at IHCP Inc.
Medical, Registration and Business Development Manager at Biocodex TR
Health Economics Manager and Medical Manager at Sanofi-aventis1

Areas of Expertise

Emrah Aras specializes in:

Medical Affairs
Strategic Planning
Digital Innovation
Data Generation
Key Opinion Leader (KOL) engagement1

Career Highlights

Throughout his career, Emrah has been involved in various aspects of the pharmaceutical industry, including:

Evidence and value development for orphan drugs and rare diseases
Project management for economic models, real-world evidence, and systematic literature reviews
Market access, pricing, and commercialization efforts
Medico-marketing activities and product launches
Health economics and reimbursement negotiations1

Emrah Aras's diverse experience in medical affairs, project management, and digital health makes him a valuable asset in his current role at Alexion Pharmaceuticals, where he leads digital health initiatives.